Ironwood Investment Management LLC Raises Stock Holdings in Enovis Co. (NYSE:ENOV)

Ironwood Investment Management LLC increased its position in Enovis Co. (NYSE:ENOV) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,155 shares of the company’s stock after purchasing an additional 545 shares during the period. Ironwood Investment Management LLC’s holdings in Enovis were worth $621,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. DAVENPORT & Co LLC grew its stake in shares of Enovis by 6.0% in the fourth quarter. DAVENPORT & Co LLC now owns 2,782,341 shares of the company’s stock worth $121,181,000 after acquiring an additional 157,216 shares during the last quarter. Royce & Associates LP grew its stake in shares of Enovis by 16.8% in the third quarter. Royce & Associates LP now owns 2,403,685 shares of the company’s stock worth $103,479,000 after acquiring an additional 346,317 shares during the last quarter. State Street Corp grew its stake in shares of Enovis by 4.3% in the third quarter. State Street Corp now owns 1,647,220 shares of the company’s stock worth $70,913,000 after acquiring an additional 68,190 shares during the last quarter. River Road Asset Management LLC grew its stake in shares of Enovis by 3.8% in the fourth quarter. River Road Asset Management LLC now owns 1,238,357 shares of the company’s stock worth $54,339,000 after acquiring an additional 45,762 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Enovis by 9.5% in the third quarter. Geode Capital Management LLC now owns 921,437 shares of the company’s stock worth $39,678,000 after acquiring an additional 80,165 shares during the last quarter. 98.45% of the stock is owned by hedge funds and other institutional investors.

Enovis Trading Up 3.4 %

Shares of NYSE:ENOV opened at $37.01 on Friday. The company has a market cap of $2.11 billion, a P/E ratio of -16.90 and a beta of 2.05. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. Enovis Co. has a 1 year low of $35.14 and a 1 year high of $62.79. The stock’s fifty day moving average price is $43.32 and its 200-day moving average price is $43.74.

Enovis (NYSE:ENOV) last posted its earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share for the quarter, beating analysts’ consensus estimates of $0.92 by $0.06. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The company had revenue of $560.98 million for the quarter, compared to the consensus estimate of $555.14 million. Sell-side analysts expect that Enovis Co. will post 2.79 earnings per share for the current year.

Analyst Ratings Changes

Separately, Needham & Company LLC lowered their price target on Enovis from $65.00 to $64.00 and set a “buy” rating on the stock in a report on Thursday, February 27th.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.